|
⚲
|
| Keyboard |
| Cormorant Asset Management LLC
✚
|
|
|---|---|
| CIK # | 0001583977 |
| Sector | Form 13F Holdings | Value ($B) | |
|---|---|---|---|
| Praxis Precision Medicines Inc | 0.3 | ||
| Helix Acquisition Corp II | 0.2 | ||
| Psivida Corp | 0.1 | ||
| Edgewise Therapeutics Inc | 0.1 | ||
| Erasca Inc | 0.1 | ||
| Rapport Therapeutics Inc | 0.1 | ||
| Alumis Inc | 0.1 | ||
| Abivax Sa | 0.1 | ||
| Helix Acquisition Corp | 0.1 | ||
| Magenta Therapeutics Inc | 0.1 | ||
| View All | |||
| Holdings by Sector ($B) |
|---|
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0001583977] | |
| 3 | [0001583977] | |
| 4 | [0001583977] | |
| SC 13D | [0001583977] | |
| SC 13G | [0001583977] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
SAV Acquisition Corp CRBP
Common Stock
|
2025-12-11 | Sell | 30,029 | $11.46 | 344,132 |
|
EyePoint Inc EYPT
Common Stock
|
2025-12-04 | Sell | 60,000 | $15.70 | 942,000 |
|
MoonLake Immunotherapeutics MLTX
Class A Ordinary Shares
|
2025-09-30 | Sell | 5,827 | $6.96 | 40,556 |
|
MoonLake Immunotherapeutics MLTX
Class A Ordinary Shares
|
2025-09-29 | Sell | 2,800,000 | $6.61 | 18,508,000 |
|
MoonLake Immunotherapeutics MLTX
Class A Ordinary Shares
|
2025-09-29 | Sell | 3,390,943 | $7.58 | 25,703,348 |
|
MoonLake Immunotherapeutics MLTX
Class A Ordinary Shares
|
2025-09-29 | Sell | 232,460 | $8.40 | 1,952,664 |
|
MoonLake Immunotherapeutics MLTX
Class A Ordinary Shares
|
2025-09-29 | Sell | 70,748 | $9.38 | 663,616 |
|
Biomea Fusion Inc BMEA
Stock Option (Right to Buy) · derivative
|
2025-06-11 | Grant | 91,970 | $0.00 | |
|
OnKure Therapeutics Inc OKUR
Class A Common Stock
|
2025-05-15 | Sell | 1,813,439 | $1.85 | 3,354,862 |
|
OnKure Therapeutics Inc OKUR
Class A Common Stock
|
2025-05-12 | Sell | 24,300 | $1.99 | 48,357 |
|
Aardvark Therapeutics Inc AARD
Series C Convertible Preferred Stock · derivative
|
2025-02-14 | Conversion | 6,780,810 | ||
|
Aardvark Therapeutics Inc AARD
Common Stock
|
2025-02-14 | Buy | 187,500 | $16.00 | 3,000,000 |
|
Aardvark Therapeutics Inc AARD
Common Stock
|
2025-02-14 | Conversion | 800,189 | ||
|
Bright Minds Biosciences Inc DRUG
Common Shares
|
2024-11-04 | Buy | 184,331 | $21.70 | 3,999,983 |
|
Bright Minds Biosciences Inc DRUG
Common Shares
|
2024-10-16 | Buy | 7,150 | $24.03 | 171,814 |
|
Bright Minds Biosciences Inc DRUG
Common Shares
|
2024-10-16 | Buy | 39,743 | $23.22 | 922,832 |
|
Bright Minds Biosciences Inc DRUG
Common Shares
|
2024-10-16 | Buy | 3,107 | $25.22 | 78,359 |
|
Bright Minds Biosciences Inc DRUG
Common Shares
|
2024-10-15 | Buy | 63,173 | $5.92 | 373,984 |
|
Bright Minds Biosciences Inc DRUG
Common Shares
|
2024-10-15 | Buy | 33,343 | $6.42 | 214,062 |
|
Bright Minds Biosciences Inc DRUG
Common Shares
|
2024-10-15 | Buy | 8,900 | $7.31 | 65,059 |
| showing 20 of 200 most recent transactions | |||||